These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10070410)

  • 21. [Role of hepatitis B virus in the etiology of serologically silent viral hepatitis].
    Emile JF
    Gastroenterol Clin Biol; 1995 Oct; 19(10):856-7. PubMed ID: 8566575
    [No Abstract]   [Full Text] [Related]  

  • 22. Identification and impact of hepatitis B virus DNA and antigens in pancreatic cancer tissues and adjacent non-cancerous tissues.
    Jin Y; Gao H; Chen H; Wang J; Chen M; Li G; Wang L; Gu J; Tu H
    Cancer Lett; 2013 Jul; 335(2):447-54. PubMed ID: 23499889
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Explanation of hepatitis B virus markers after hepatitis B vaccines inoculation].
    Chen H; Zhu QR
    Zhonghua Gan Zang Bing Za Zhi; 2003 Apr; 11(4):240. PubMed ID: 12716528
    [No Abstract]   [Full Text] [Related]  

  • 24. [Hepatitis B virus markers in the internist's practice].
    Ivashkin VT; Khazanov AI; Ivlev AS; Vasil'eva AP; Rumiantsev ON; Krivoruchko VA; Lytsar' BN; Izgorodin AS
    Klin Med (Mosk); 1991 Sep; 69(9):51-4. PubMed ID: 1803151
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleic acid testing to detect HBV infection in blood donors.
    Stramer SL; Wend U; Candotti D; Foster GA; Hollinger FB; Dodd RY; Allain JP; Gerlich W
    N Engl J Med; 2011 Jan; 364(3):236-47. PubMed ID: 21247314
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Occult hepatitis B virus infection among anti-HBc positive blood donors: Necessitates substitution of screening by HBV NAT.
    Panhotra BR; Bahrani A; Joshi CS; ul Hassan Z
    J Infect; 2005 Oct; 51(3):263. PubMed ID: 16125778
    [No Abstract]   [Full Text] [Related]  

  • 27. [Clinical view of acute hepatitis B].
    Tanaka N; Arakawa Y; Moriyama M
    Nihon Rinsho; 2004 Aug; 62 Suppl 8():242-7. PubMed ID: 15453323
    [No Abstract]   [Full Text] [Related]  

  • 28. [Highly sensitive methods for the serological,diagnosis of hepatitis B and their clinico-epidemiological significance].
    Botsvadze ESh; Aleksishvili MM; Gegeshidze TN; Mosakhlishvili NG
    Ter Arkh; 1990; 62(2):79-82. PubMed ID: 2336630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Investigation of hepatitis B virus infection in blood donors].
    Wang D; Liu C; Shen Y; Tan D
    Hunan Yi Ke Da Xue Xue Bao; 1998; 23(6):540-2. PubMed ID: 10806762
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantification of hepatitis B virus DNA over a wide range from serum for studying viral replicative activity in response to treatment and in recurrent infection.
    Ranki M; Schätzl HM; Zachoval R; Uusi-Oukari M; Lehtovaara P
    Hepatology; 1995 Jun; 21(6):1492-9. PubMed ID: 7768492
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hepatitis E virus as an etiology of acute exacerbation of previously unrecognized asymptomatic patients with hepatitis B virus-related chronic liver disease.
    Kumar M; Sharma BC; Sarin SK
    J Gastroenterol Hepatol; 2008 Jun; 23(6):883-7. PubMed ID: 18070014
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Viral marker related to antigen and antibody of hepatitis B virus].
    Arase Y
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():439-42. PubMed ID: 20942098
    [No Abstract]   [Full Text] [Related]  

  • 33. Reliability of rapid testing for hepatitis B in a region of high HIV endemicity.
    Davies J; van Oosterhout JJ; Nyirenda M; Bowden J; Moore E; Hart IJ; Zijlstra EE; Chaponda M; Faragher B; Beeching NJ; Beadsworth MB
    Trans R Soc Trop Med Hyg; 2010 Feb; 104(2):162-4. PubMed ID: 19931107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Can the serological status of anti-HBc alone be considered a sentinel marker for detection of occult HBV infection?
    Vitale F; Tramuto F; Orlando A; Vizzini G; Meli V; Cerame G; Mazzucco W; Virdone R; Palazzo U; Villafrate MR; Tagger A; Romano N
    J Med Virol; 2008 Apr; 80(4):577-82. PubMed ID: 18297707
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Routine hepatitis B virus DNA testing in human immunodeficiency virus-infected patients with positive hepatitis B core antibody but negative hepatitis B surface antigen is not justified by current evidence.
    Núñez M
    Hepatology; 2010 Mar; 51(3):1087-8. PubMed ID: 19960553
    [No Abstract]   [Full Text] [Related]  

  • 36. International collaborative study proposal for the characterization of occult hepatitis B virus infection identified by nucleic acid or anti-HBc screening.
    Allain JP
    Vox Sang; 2007 Apr; 92(3):254-7. PubMed ID: 17348876
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Changing scene in hepatitis B serology interpretation.
    Chan HL
    Hosp Med; 2002 Jan; 63(1):16-9. PubMed ID: 11828810
    [TBL] [Abstract][Full Text] [Related]  

  • 38. From the Medical Board of the National Psoriasis Foundation: Recommendations for screening for hepatitis B infection prior to initiating anti-tumor necrosis factor-alfa inhibitors or other immunosuppressive agents in patients with psoriasis.
    Motaparthi K; Stanisic V; Van Voorhees AS; Lebwohl MG; Hsu S;
    J Am Acad Dermatol; 2014 Jan; 70(1):178-86. PubMed ID: 24220724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serological detection of hepatitis B viral infection by a panel of solid-phase enzyme-linked immunosorbent assays (ELISA).
    Tsitsilonis OE; Thrasyvoulides A; Balafas A; Voutsas JF; Papamichail M; Lymberi P
    J Pharm Biomed Anal; 2004 Mar; 34(4):811-22. PubMed ID: 15019059
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Elements with prognostic value in the chronic evolution of viral hepatitis. Markers of the evolution].
    Banciu T
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1986; 38(2):161-70. PubMed ID: 2875504
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.